Trials / Unknown
UnknownNCT00986713
Value of Amphotericin B Inhalation for Prophylaxis of Invasive Pulmonary Aspergillosis After Renal Transplantation
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- Sponsor
- Capital Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether inhalation with aerosolized amphoterin B 10mg/d is more effective than aerosolized amphoterin B 2mg/d to reduce the incidence of invasive pulmonary aspergillosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Amphotericin B | Aerosolized Amphotericin B,2mg/day or 10mg/day |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2010-09-01
- Completion
- 2010-10-01
- First posted
- 2009-09-30
- Last updated
- 2009-09-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00986713. Inclusion in this directory is not an endorsement.